Saturday 18 November 2017
Contact US    |    Archive
Reuters
3 months ago

New data boosts case for extended use of AstraZeneca heart drug

LONDON (Reuters) - AstraZeneca s blood-thinner Brilinta cuts the risk of cardiovascular death by 29

Read on the original site


Hashtags:   

New

 | 

data

 | 

boosts

 | 

case

 | 

for

 | 

extended

 | 

use

 | 

AstraZeneca

 | 

heart

 | 

drug

 | 
Most Popular (6 hours)

Most Popular (24 hours)

That s wonderland

- en.gmw.cn

Most Popular (a week)

Categories - Countries
All News
All Countries